Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance

DCGI gives limited approval to market first allogeneic cell therapy product in India

Cipla Announces Launch of Hepcvir-L for Chronic Hepatitis C Genotype 1 Patients

Cipla launches novel “5 in 1” anti-ageing skin care product Cutisera™ developed by Stempeutics

Cipla ready to launch low-dose Efavirenz 400 mg

Cipla appoints Naina Lal Kidwai as an Independent Director on its Board

Cipla announces Q2 FY1516 Unaudited Consolidated Financial Results

Cipla announces Q2 FY1516 Unaudited Consolidated Financial Results

Cipla Strengthens its Focus on Biotech

Cipla Medpro (Pty) Ltd. Partners with Serum Institute India (SII) to Provide Vaccines in South Africa

Subscribe to